Public Citizen Agrees With AMA On (Drug) Liability, Petitions FDA On Generic Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
The consumer watchdog group asks that ANDA holders be able to file a supplemental label change through the changes-being-effected procedure.
You may also be interested in...
Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change
In Pliva v. Mensing, the high court said it was impossible for generic manufacturers to comply with both state tort laws and FDA regulations requiring them to have the same labels as those for brand name counterparts.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.